Intravitreal Bevacizumab In Diabetic Macular Edema At RSUP Cipto Mangunkusumo in 2017
Introduction: Diabetic Macular Edema (DME) is a manifestation of diabetic retinopathy and is the most common cause of vision loss in diabetics. The incidence of DME has a tendency to increase, concomitant with the prevalence of diabetes globally by more than 50% from 2000 to 2030. This study aims to...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
International Journal of Retina
2019-09-01
|
| Серии: | IJRETINA (International Journal of Retina) |
| Online-ссылка: | https://ijretina.com/index.php/ijretina/article/view/70 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|